|
KMID : 0670820120170010017
|
|
Korean Journal of Medical Mycology
2012 Volume.17 No. 1 p.17 ~ p.24
|
|
|
The Clinical Characteristics, Therapeutic Outcome and Prognostic Factors for Invasive Pulmonary Aspergillosis: A Single-Center Experience and Review of the Literature
|
|
Park Se-Yoon
Lee Eun-Jung
Kim Tae-Hyong
Choo Eun-Ju
Jeon Min-Hyok
Kong Min-Gyu
Choo Jin-Woo
|
|
|
Abstract
|
|
|
Background: Despite advances in microbiological diagnosis and effective antifungal treatment, invasive pulmonary aspergillosis (IPA) is a still major cause of mortality in immunocompromised patients.
Objective: The aim of this study is to analyze clinical characteristics, treatment outcome and prognostic factors for IPA.
Methods: Between May 2003 and March 2011, we retrospectively studied all patients with IPA in our facility.
Results: A total 37 cases were identified. Hematologic malignancies were the leading underlying disease for 27 (27/37, 73.0%) patients. Neutropenic period between the onset of neutropenia and the diagnosis of IPA was 15.0 days. The most common symptom was fever (35/37, 94.6%). The principal findings of chest computed tomography (CT) were segmental or air space consolidation (17/37, 45.9%) followed by halo sign (13/37, 35.1%), and ground-glass attenuation (11/37, 29.7%). Amphotericin B was the initial treatment for 36 (36/37, 97.3%) patients. Voriconazole was subsequently substituted for Amphotericin B in 25 (35/36, 97.2%) patients. The 30-day mortality rate was 24.3% (9/37). The 30-day mortality rate was associated with a failure to recover from neutropenia (p=0.048) or persistent fever during treatment (p=0.003). Two patients were lost to follow-up. Overall mortality was 62.9% (22/35).
Conclusion: IPA remains a serious condition with failure to recover from neutropenia or persistent fever during treatment associated with a high 30-day mortality rate.
|
|
|
KEYWORD
|
|
|
Invasive pulmonary aspergillosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|